Physicians Begin Prescribing GLP-1 Medications to Children in Louisiana

Parents of children in Baton Rouge, Louisiana, now have a new medical option for managing pediatric weight. Physicians are prescribing GLP-1 receptor agonists, a class of drugs widely used by adults for weight loss and diabetes management, to select groups of young patients. This shift represents a change in clinical practice for families whose children have not responded to standard dietary and exercise regimens.

Dr. Rhea Rogers, a board-certified physician and host of the program Aging Untold, explained that lifestyle changes are sometimes insufficient due to biological factors. She noted that genetics and hormonal dysregulation can prevent weight loss through diet and movement alone. Rogers stated that when a child becomes significantly overweight, the body enters a state of hormonal imbalance that requires medical intervention.

Rogers described GLP-1 agonists as effective tools for reducing what she called food noise and food chatter. She also characterized the medication as anti-inflammatory. Her assessment suggests that these drugs address the physiological drivers of weight gain rather than just the behavioral aspects. She emphasized that the medication is a tool within a larger treatment plan, not a standalone cure.

Clinical guidelines for prescribing these drugs to children are specific. For patients with diabetes, the age requirement starts at 10 years old. For weight loss purposes, experts identify the ideal candidate as a child with a body mass index at or above the 95th percentile. These patients must also have a history of unsuccessful lifestyle modifications or developed hormone problems that necessitate medical support.

The cost of the medication remains a primary obstacle for many households. Families who cannot afford the drugs or who prefer non-pharmaceutical approaches are advised to continue with well-balanced meals and healthy lifestyle habits. The program serving these students in Baton Rouge focuses on education about healthy eating and exercise as part of a statewide effort to lower obesity rates.

Rogers cautioned that the treatment is not a miracle drug. She advised that physicians must treat the entire scenario, integrating medication with other health factors. This approach aims to manage the underlying conditions while providing the necessary physiological support for weight reduction.

The introduction of GLP-1s into pediatric care marks a specific change in how doctors treat childhood obesity. The decision to prescribe involves a review of the child's medical history, including BMI percentiles and previous attempts at weight management through lifestyle changes.